1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy.

Brickman, A S

1,25-dihydroxycholecalciferol. Effect on skeletal lesions and plasma parathyroid hormone levels in uremic osteodystrophy. [electronic resource] - Archives of internal medicine Nov 1974 - 883-8 p. digital

Publication Type: Clinical Trial; Journal Article

0003-9926

10.1001/archinte.134.5.883 doi


Adult
Antigens
Biopsy
Calcium--blood
Chronic Kidney Disease-Mineral and Bone Disorder--drug therapy
Clinical Trials as Topic
Dihydroxycholecalciferols--adverse effects
Drug Evaluation
Female
Humans
Hydroxycholecalciferols--therapeutic use
Hypercalcemia--chemically induced
Hyperparathyroidism, Secondary--drug therapy
Ilium--pathology
Male
Middle Aged
Osteomalacia--drug therapy
Parathyroid Hormone--blood
Phosphorus--blood